Why the study?
Does the systemic immune-inflammation index predict the no-reflow phenomenon in patients undergoing primary PCI for acute STEMI?
Does the systemic immune-inflammation index predict the no-reflow phenomenon in patients undergoing primary PCI for acute STEMI?
High systemic immune-inflammation index may be a promising indicator for predicting the no-reflow phenomenon in STEMI patients undergoing primary PCI.
SII may aid no-reflow risk stratification in primary PCI for STEMI; hypothesis-generating and requires prospective validation.
SII levels are independently associated with the NRP in patients undergoing primary PCI for acute STEMI. High SII may be a promising indicator for the prediction of NRP in these patients.
No takes yet. Share an insight, caveat, or question.
Esenboğa et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: